The infection hypothesis is gaining traction in Alzheimer’s research. Traditionally, protein deposits in the brain were considered the principal cause of dementia. However, recent studies increasingly point to viruses and subsequent immune reactions as significant contributors.
Researchers are particularly examining the influence of herpes viruses and exploring whether vaccinations and antiviral therapies can provide protection.
Herpes Viruses Drastically Increase Risk
A study published in the journal “Neuron” illustrates a clear correlation: individuals with viral encephalitis have a 20- to 30-fold increased risk of developing Alzheimer’s disease. The Herpes Simplex Virus Type 1 (HSV-1) is a primary focus.
When combined with the genetic risk factor APOE4, analyses suggest the risk escalates to twelve times. The theory posits that recurring reactivations of dormant viruses trigger chronic inflammation and brain damage.
In addition to HSV-1, researchers are also considering Varicella-Zoster Virus (shingles) and the bacterium Porphyromonas gingivalis (associated with gum disease) as potential influencing factors.
The Immune System Accelerates Cognitive Decline
It’s not just the virus itself that may be culpable; rather, the immune reaction it triggers could drive cognitive decline. A July 2026 study published in “Brain” using mouse models indicated that infections with Cytomegalovirus (CMV) led to worsened memory deficits.
Memory loss and concentration problems might be early signs of gradual changes occurring in the brain. To assess mental fitness discreetly, this anonymous 7-question self-test allows individuals to gauge their cognitive health in just two minutes. Start the free dementia self-test now
Specific T-cells (CD8+) infiltrated the brain, exacerbating the condition. Notably, an antiviral treatment with Valganciclovir improved the cognitive performance of these mice.
Simultaneously, scientists from King’s College London discovered a novel form of programmed cell death known as karyoptosis. In tissue samples from Alzheimer’s patients, 35% of cells displayed traits of this process, compared to only 15% in healthy individuals. The interaction between the p38 MAP kinase and the protein LaminB1 could present a new therapeutic target.
Vaccinations Reduce Risk by 20 Percent
Existing medical interventions could significantly influence dementia risk. A “Nature” analysis of over 280,000 seniors in Wales found that vaccination against the Varicella-Zoster Virus led to a roughly 20% reduction in new Alzheimer diagnoses over seven years, particularly notable in women.
In addition to medical advances, proactive measures play a vital role in preserving mental health. Discover how to enhance your cognitive fitness sustainably with 11 practical everyday exercises and targeted nutrition. Secure the free brain training guide here
A 2018 study from Taiwan suggested that consistent antiviral medications could potentially reduce dementia risk by up to 90% over ten years.
Roche is also pursuing innovative approaches, currently testing the antibody Trontinemab in a Phase 3 study involving cognitively unimpaired individuals with Alzheimer’s biomarkers. The aim is to delay the onset of clinical symptoms.
CO2 Inhalation and AI Diagnostics
Beyond viral causes, physiological processes are coming under scrutiny. A pilot study presented at AAIC 2026 in London demonstrated that inhaling 5% CO2 activates the glymphatic system. This results in a heightened removal of beta-amyloid proteins into the bloodstream, mimicking processes that occur during deep sleep.
For early detection, researchers are leveraging Artificial Intelligence. A method published in “GeroScience” in 2026 analyzes nocturnal brainwaves using AI to identify Alzheimer’s with high accuracy. Blood tests for p-tau217 can predict risks up to ten years ahead based on study findings.
Experts also highlight that avoidable risks exist. For instance, SGLT2 inhibitors reportedly lower dementia risk by 43%, while GLP-1 receptor agonists reduce it by 33%.
Disclaimer: This article is not financial advice; it does not constitute a recommendation to buy or sell. Information regarding prices, companies, and markets is without guarantee; changes may occur at any time. Trading in stocks can lead to substantial losses. Our contributions are created and reviewed partially automated with AI assistance.
